跳至主要内容
临床试验/NL-OMON56195
NL-OMON56195招募中不适用

The effect of Transcutaneous Vagal Nerve Stimulation on the processing of visceral pain signals: a High Resolution fMRI Study in Healthy Volunteers - Effects of tVNS on visceral pain

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Of female sex;
  • Healthy participants (defined as those without a pre-existing medical
  • comorbidity)
  • Age between 18 and 40 years;
  • BMI between 18 and 30 kg/m2;
  • All subjects should use some form of contraception (for IUDs only Mirena is
  • All subjects should be right-handed.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Presence of metallic prostheses, pacemakers, metal clips on blood vessels,
  • metal parts in the eye, an intrauterine device (with the exception of the
  • Mirena IUD), metal braces, tattoos and/or other metal objects;
  • History of major head trauma or head/brain surgery;
  • History of claustrophobia;
  • History of severe or chronic cardiovascular, respiratory, urogenital,
  • gastrointestinal/ hepatic, haematological/immunologic, HEENT (head, ears, eyes,
  • nose, throat), dermatological/connective tissue, musculoskeletal,
  • metabolic/nutritional, endocrine, neurological/psychiatric diseases, major
  • surgery and/or laboratory assessments which might limit participation in or
  • completion of the study protocol;
  • Use of regular medication, including vitamin and iron supplementation, except
  • oral contraceptives, within 14 days prior to start of the study;
  • Pregnancy, lactation, wish to become pregnant;
  • High alcohol consumption (>15 alcoholic units consumed per week);
  • Using drugs of abuse;
  • Administration of investigational drugs or participation in any scientific
  • intervention study which may interfere with this study (to be decided by the
  • principle investigator), in the 180 days prior to the study;
  • Participants unable to provide informed consent
  • Participants with any systemic disease or medications that may influence the
  • autonomic nervous system (e.g. beta-agonists or Parkinson*s disease)
  • Current smokers or current use of nicotine in any other way (including
  • E-cigarettes and patches)
  • History of clinical anxiety or depression, or a hospital anxiety or
  • depression score >8
  • Participants whom score 8 or more on the HADS-questionnaire at study
  • commencement
  • Patient whom have cardiovascular conduction problems
  • Patient with cochlear implants
  • Not meeting any of the inclusion criteria above
  • Any evidence of structural brain abnormalities examined by anatomical MRI
  • will lead to exclusion

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

The effect of Transcutaneous Vagal Nerve Stimulation... | 临床试验